Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment

Gastrointestinal Endoscopy

Volumn 71, Issue 3, 2010, Pages 527-534

  Gotthardt, Daniel N ^a   Rudolph, Gerda ^a   Klöters Plachky, Petra ^a   Kulaksiz, Hasan ^a   Stiehl, Adolf ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; URSODEOXYCHOLIC ACID;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL CHOLANGITIS; BALLOON DILATATION; BILE DUCT CARCINOMA; BILE DUCT DISEASE; BILE DUCT OBSTRUCTION; BILE DUCT PERFORATION; CHOLANGITIS; CHOLEDOCHOJEJUNOSTOMY; CLINICAL TRIAL; COMMON BILE DUCT; DRUG DOSE INCREASE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC THERAPY; FEMALE; FOLLOW UP; HEPATIC DUCT; HUMAN; INTRAHEPATIC BILE DUCT; LIVER DISEASE; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANCREATITIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; STENT; TERTIARY HEALTH CARE; UNIVERSITY HOSPITAL;

BALLOON DILATATION; CHOLANGITIS, SCLEROSING; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; PROSPECTIVE STUDIES; RETREATMENT; STENTS; TREATMENT OUTCOME;

EID: 77349114492     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2009.10.041     Document Type: Article

References (38)

1. Chapman R.W., Arborgh B.A., Rhodes J.M., et al. Primary sclerosing cholangitis-a review of its clinical features, cholangiography and hepatic histology. Gut 21 (1980) 870-877
2. Wiesner R.H., and LaRusso N.F. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 79 (1980) 200-206
3. Farrant M.J., Hayllar K.M., Wilkinson M.L., et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 100 (1991) 1710-1717
4. Lee Y.-M., and Kaplan M.M. Primary sclerosing cholangitis. N Engl J Med 332 (1995) 924-933
5. Broome U., Olson R., Lööf L., et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38 (1996) 610-615
6. Beuers U., Spengler U., Kruis W., et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo controlled trial. Hepatology 16 (1992) 707-714
7. Stiehl A., Walker S., Stiehl L., et al. Effects of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3 year pilot study with a placebo- controlled study period. J Hepatol 20 (1994) 57-64
8. Lindor K.D.t.M.P.S.C./U.D.C.A.S.Group. Ursodiol for the treatment of primary sclerosing cholangitis. N Engl J Med 336 (1997) 691-695
9. Mitchell S.A., Bansi D.S., Hunt N., et al. A preliminary trial of high dose ursodeoxycholic acid in primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled study. Gastroenterology 121 (2001) 900-907
10. Harnois D.M., Angulo P., Jorgensen R.A., et al. High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis. Am J Gastroenterol 96 (2001) 1558-1562
11. Olsson R., Boberg K.M., de Muckadell O.S., et al. High-dose ursodeoxycholic acid in primary sclerosing cholangitis. A five year multicenter randomized controlled study. Gastroenterology 129 (2005) 1464-1472
12. Cullen S.N., Rust C., Fleming K., et al. High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective. J Hepatol 48 (2008) 792-800
13. Stiehl A., Rudolph G., Sauer P., et al. Efficacy of ursodeoxycholic acid treatment and endoscopic dilatation of major duct stenoses in primary sclerosing cholangitis. An 8 years prospective study. J Hepatol 26 (1997) 560-566
14. Lindor K.D., Kowdley K.V., Luketic V.A., et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 50 (2009) 808-814
15. Stiehl A., Rudolph G., Klöters-Plachky P., et al. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol 36 (2002) 151-156
16. Grijm R., Huibregtse K., Bartelsman J., et al. Therapeutic investigations in primary sclerosing cholangitis. Dig Dis Sci 31 (1986) 792-798
17. Johnson G.K., Geenen J.E., Venu R.P., et al. Endoscopic treatment of biliary duct strictures in sclerosing cholangitis: follow up assessment of a new therapeutic approach. Gastrointest Endosc 33 (1987) 9-12
18. Craig P.I., and Hatfield R.W. Endoscopic therapy in primary sclerosing cholangitis. Eur J Gastroentrol Hepatol 4 (1992) 284-287
19. Gaing A.A., Geders J.M., Cohen S.A., et al. Endoscopic management of primary sclerosing cholangitis: review, and report of an open series. Am J Gastroenterol 88 (1993) 2000-2008
20. Lee J.G., Schutz S.M., England R.E., et al. Endoscopic therapy of sclerosing cholangitis. Hepatology 21 (1995) 661-667
21. van Milligen A.W.M., van Bracht J., Rauws E.A., et al. Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest Endosc 44 (1996) 293-299
22. Kaya M., Petersen K.M., Angulo P., et al. Balloon dilatation compared to stenting of dominant strictures in primary sclerosing cholangitis. Am J Gastroenterol 96 (2001) 1059-1066
23. Baluyut A.R., Sherman S., Lehman G.A., et al. Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. Gastrointest Endosc 53 (2001) 308-312
24. Rudolph G., Gotthardt D., Klöters-Plachky P., et al. Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. J Hepatol 51 (2009) 149-155
25. Rost D., Rudolph G., Kloeters-Plachky P., et al. Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis. Hepatology 40 (2004) 693-698
26. Kulaksiz H., Rudolph G., Kloeters-Plachky P., et al. Biliary Candida infections in primary sclerosing cholangitis. J Hepatol 45 (2006) 711-716
27. Rudolph G., Kloeters-Plachky P., Rost D., et al. The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid. Eur J Gastroenterol Hepatol 19 (2007) 487-491
28. Olsson R., Björnsson E., Bäckman L., et al. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. J Hepatol 28 (1998) 426-432
29. Pohl J., Ring A., Stremmel W., et al. The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 18 (2006) 69-74
30. Tischendorf J.W.T., Hecker H., Krüger M., et al. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol 102 (2007) 107-114
31. Chapman MH, J Wittmann J, Webster GJ, et al. A single center experience of dominant biliary strictures and cholangiocarcinoma in primary sclerosing cholangitis (PSC), Abstract, XX. International Bile Acid Meeting, Amsterdam, 2008, Abstract 93.
32. Björnsson E., Lindqvist-Ottosson J., Asztely M., et al. Dominant strictures in patient with primary sclerosing cholangitis. Am J Gastroenterol 99 (2004) 502-508
33. Fulcher A.S., Turner M.A., Franklin K.J., et al. Primary sclerosing cholangitis: evaluation with MR cholangiography. A case-control study. Radiology 215 (2000) 71-80
34. Textor H.J., Flacke S., Keller E., et al. Three-dimensional magnetic resonance cholangiopancreaticography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography. Endoscopy 34 (2002) 984-990
35. Berstad A.E., Aabakken L., Smith H.J., et al. Diagnostic accuracy of magnetic resonance retrograde cholangiography in primary sclerosing cholangitis. Clin Gastroenterol Hepatol 4 (2006) 514
36. Moff S.L., Kamel I.R., Eustace J., et al. Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography. Gastrointest Endosc 64 (2006) 219-223
37. Weber C., Kuhlencordt R., Grotelueschen R., et al. Magnetic resonance cholangiopancreaticography in the diagnosis of primary sclerosing cholangitis. Endoscopy 40 (2007) 739-745
38. Garioud A., Seksik P., Chrétien Y., et al. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study. Eur J Gastroenterol Hepatol (2009) Sep 22 [Epub ahead of print]